New 2013 Induced Pluripotent Stem Cell (iPSC) Industry
Report Details Market Trends, Metrics and Financials
BioInformant Worldwide, LLC, has recently released the market intelligence report titled “The
Complete 2012-13 Induced Pluripotent Stem Cell Industry Report - Market Metrics, Dynamics, and
Trends.” It provides strategic insights that guide the decision-making of companies that develop and
manufacture induced pluripotent stem cell (iPSC) research products.
The market intelligence report presents financial metrics for the Induced Pluripotent Stem Cell
Industry, as well as key findings discovered from surveying a global audience of iPSC researchers (293
respondents). It reveals iPSC product and industry trends with five-year projections; informs about
iPSC grants, patents and publications; identifies profitable opportunities for producers of iPSC
products, and presents critical insights into future tools that iPSC scientists will require. In addition, it
clearly denotes preferred species for iPSC research, analyzes the competitive environment for iPSC
research products, and breaks down market share by competitor – providing an overall view of the
iPSC product landscape.
iPSCs are adult stem cells that have been transformed into embryotic-like stem cells through the
manipulation of gene expression and similar methods. Despite some initial concerns, induced
pluripotent stem cells (iPSC) are now sold by more than half (53.4%) of U.S. research product
companies and 38.7% of research product companies worldwide.
"It is clear that iPSC products are in high demand within the scientific community. Currently, it is
difficult for stem cell research product suppliers, like BD BioSciences, Life Technologies, and others, to
know what products iPSC scientists will demand in 2013 and beyond. The needs of scientists are
constantly changing, so this market intelligence report reveals profitable opportunities for providers of
iPSC research products to pursue,” says BioInformant.
For the past five decades, stem cell research has provided insights to the inner workings of the body
and cell regeneration. “Therapeutic applications of iPSCs represent the future of medicine," says
BioInformant. The scientific community believes that one day stem cell research will assist in finding
viable treatments for crippling diseases such as Parkinson’s, Alzheimer’s, spinal cord injuries and
“This is a must-read industry report for research supply companies to optimally position themselves to
sell iPSC research products. This is a lucrative and rapidly expanding market,” explains BioInformant.
“The study will help you understand your key strengths relative to the competition.”
The study is backed by a 100% money back guarantee, to ensure that the strategies, findings and
tools are found helpful.
To learn more about “The Complete 2012-13 Induced Pluripotent Stem Cell Industry Report - Market
Metrics, Dynamics, and Trends,” please visit http://www.aarkstore.com/reports/The-Complete-2012-